Viewing Study NCT00084656


Ignite Creation Date: 2025-12-24 @ 11:18 PM
Ignite Modification Date: 2026-01-02 @ 4:13 PM
Study NCT ID: NCT00084656
Status: COMPLETED
Last Update Posted: 2022-04-14
First Post: 2004-06-10
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Monoclonal Antibody Therapy and Vaccine Therapy in Treating Patients With Resected Stage III or Stage IV Melanoma
Sponsor: Bristol-Myers Squibb
Organization: